- Home
- PRME vs TXMD Comparison
PRME vs TXMD Comparison
Compare PRME & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- TXMD
- Stock Information
- Founded
- PRME 2019
- TXMD 2008
- Country
- PRME United States
- TXMD United States
- Employees
- PRME N/A
- TXMD N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- PRME Health Care
- TXMD Health Care
- Exchange
- PRME Nasdaq
- TXMD Nasdaq
- Market Cap
- PRME 191.7M
- TXMD 13.5M
- IPO Year
- PRME 2022
- TXMD N/A
- Fundamental
- Price
- PRME $4.29
- TXMD $1.14
- Analyst Decision
- PRME Buy
- TXMD
- Analyst Count
- PRME 6
- TXMD 0
- Target Price
- PRME $9.38
- TXMD N/A
- AVG Volume (30 Days)
- PRME 5.4M
- TXMD 34.6K
- Earning Date
- PRME 08-04-2025
- TXMD 08-11-2025
- Dividend Yield
- PRME N/A
- TXMD N/A
- EPS Growth
- PRME N/A
- TXMD N/A
- EPS
- PRME N/A
- TXMD N/A
- Revenue
- PRME $3,846,000.00
- TXMD $1,841,000.00
- Revenue This Year
- PRME $104.12
- TXMD $427.09
- Revenue Next Year
- PRME $108.24
- TXMD N/A
- P/E Ratio
- PRME N/A
- TXMD N/A
- Revenue Growth
- PRME 550.76
- TXMD 53.55
- 52 Week Low
- PRME $1.11
- TXMD $0.70
- 52 Week High
- PRME $6.75
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- PRME 69.86
- TXMD 43.84
- Support Level
- PRME $4.01
- TXMD $1.13
- Resistance Level
- PRME $4.83
- TXMD $1.24
- Average True Range (ATR)
- PRME 0.52
- TXMD 0.09
- MACD
- PRME 0.15
- TXMD 0.01
- Stochastic Oscillator
- PRME 74.82
- TXMD 59.62
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.